Glassia is an intravenous prescription medication indicated for chronic augmentation and maintenance therapy in adults with emphysema due to congenital deficiency of alpha1-proteinase inhibitor. Glassia is administered by intravenous infusion once a week. In clinical studies common side effects included headache and dizziness.Your doctor should discuss other rare but potentially serious side effects and potential drug interactions with you prior to treatment.


Click here to view Manufacturers Website

800-809-1265 | info@palmettoinfusion.com
Copyright ©2019 Palmetto Infusion. All Rights Reserved. Myrtle Beach Web Design by InterCoastal Net Designs